Bajaj Finserv Healthcare Fund - IDCW - Regular Plan

Other Plans and Options
  • 0.07 %Nav, as on 07-03-2025

  • Previous Nav

  • Net Change on 07-03-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI -8.29 -10.99 13.97 21.13 23.90 15.26

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
NIPPON INDIA PHARMA FUND - IDCW Option Jun 05, 2004 9.24 19.89 23.87 1.82 7,637.04
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option Jul 13, 2018 16.43 24.47 26.60 1.93 4,611.47
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jul 03, 1999 17.63 24.32 25.27 1.94 3,312.89
UTI Healthcare Fund - Regular Plan - IDCW Aug 25, 1999 15.93 20.84 23.54 2.22 1,057.17
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW Jul 10, 2019 6.97 18.55 19.94 2.33 754.75

Fund Holdings as on 28-February-2025

  • Divi's Laboratories Limited

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Dr. Reddy's Laboratories Limited

  • Clearing Corporation of India Ltd

  • Apollo Hospitals Enterprise Limited

  • Biocon Limited

  • Piramal Pharma Limited

  • Syngene International Limited

  • Neuland Laboratories Limited

  • Torrent Pharmaceuticals Limited

  • Emcure Pharmaceuticals Limited

  • IPCA Laboratories Limited

  • Orchid Pharma Limited

  • Hindustan Unilever Limited

  • Abbott India Limited

  • Net Receivables / (Payables)

  • Sanofi Consumer Healthcare India Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Glenmark Pharmaceuticals Limited

  • Zydus Wellness Limited

  • Vijaya Diagnostic Centre Limited

  • Rainbow Childrens Medicare Limited

  • Alkem Laboratories Limited

  • Emami Limited

  • Pfizer Limited

  • Lupin Limited

  • Dr. Lal Path Labs Limited

  • Marico Limited

  • Alembic Pharmaceuticals Limited

  • Mankind Pharma Limited

  • Jubilant Pharmova Limited

  • MedPlus Health Services Limited

  • Colgate Palmolive (India) Limited

  • Medi Assist Healthcare Services Limited

  • AstraZeneca Pharma India Limited

  • Shaily Engineering Plastics Limited

  • Neogen Chemicals Limited

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Household & Personal Products

  • Business Support

  • Consumer Food

  • Plastic Products

  • Chemicals

View More

Fund Manager

  • Cash

  • Equity

View More

About Bajaj Finserv Healthcare Fund

Scheme Analysis

Bajaj Finserv Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Bajaj Finserv Mutual Fund. It was launched on 27-Dec-2024 and currently has an AUM of ₹283.11 crore. Bajaj Finserv Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index.

The NAV of Bajaj Finserv Healthcare Fund ended up ₹0.01(0.07%)yesterday to ₹8.819.

Among its top 3 holdings the fund has exposure to Divi's Laboratories Limited, and

The Bajaj Finserv Healthcare Fund is managed by Nimesh Chandan and Sorbh Gupta.

Fund House Contact

S. No. 208/1B, Lohagaon Viman Nagar Pune - 411014

1800-309-3900
service@bajajamc.com
020-67672550